Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. حسب Ayana Ablayeva (22103708)

الموضوعات:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

OPV coverage by nationwide and at study areas (as per enrollment period). حسب Zahid Hasan Khan (6281396)

الموضوعات:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Reasons given by parents/guardians of incompletely vaccinated children (Zero-dose and one-dose OPV vaccination). حسب Zahid Hasan Khan (6281396)

الموضوعات:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Distribution of background characteristics of the study participants (N = 18255). حسب Zahid Hasan Khan (6281396)

الموضوعات:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). حسب Ayana Ablayeva (22103708)

الموضوعات:

Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization حسب figshare admin karger (2628495)

"…Participants were categorized by LVEDD change from baseline: No Change (<5 mm), Decreased (≥5 mm), and Increased (≥5 mm). Results: A decrease in LVEDD was observed in 24% of participants (mean change -9±3 mm) and was significantly associated with older age, female sex, decreased volumes, concentric remodeling and diastolic dysfunction. …"

Overcoming the Limitations of Transition-Metal Catalysis in the Chemoenzymatic Dynamic Kinetic Resolution (DKR) of Atropisomeric Bisnaphthols حسب Kun Wang (134525)

"…Such a reliable ligand offers π* orbitals, allowing additional metal-to-ligand d−π* back-donation, which can significantly enhance coordination effects between the ligand and metal. …"

Overcoming the Limitations of Transition-Metal Catalysis in the Chemoenzymatic Dynamic Kinetic Resolution (DKR) of Atropisomeric Bisnaphthols حسب Kun Wang (134525)

"…Such a reliable ligand offers π* orbitals, allowing additional metal-to-ligand d−π* back-donation, which can significantly enhance coordination effects between the ligand and metal. …"

Table 2_The protective role of muscone in the development of COPD.xlsx حسب Tiantian Feng (2851097)

"…</p>Results<p>The body weight of COPD mice was significantly lower than that of Muscone-treated COPD mice, consistent with decreased lung function, accompanied by reduced circulating and lung IL-38 levels. …"

Table 4_The protective role of muscone in the development of COPD.xlsx حسب Tiantian Feng (2851097)

"…</p>Results<p>The body weight of COPD mice was significantly lower than that of Muscone-treated COPD mice, consistent with decreased lung function, accompanied by reduced circulating and lung IL-38 levels. …"

Table 5_The protective role of muscone in the development of COPD.xlsx حسب Tiantian Feng (2851097)

"…</p>Results<p>The body weight of COPD mice was significantly lower than that of Muscone-treated COPD mice, consistent with decreased lung function, accompanied by reduced circulating and lung IL-38 levels. …"

Table 1_The protective role of muscone in the development of COPD.xlsx حسب Tiantian Feng (2851097)

"…</p>Results<p>The body weight of COPD mice was significantly lower than that of Muscone-treated COPD mice, consistent with decreased lung function, accompanied by reduced circulating and lung IL-38 levels. …"

Table 3_The protective role of muscone in the development of COPD.xlsx حسب Tiantian Feng (2851097)

"…</p>Results<p>The body weight of COPD mice was significantly lower than that of Muscone-treated COPD mice, consistent with decreased lung function, accompanied by reduced circulating and lung IL-38 levels. …"

RTA408 promotes Nrf2 expression. حسب Hongmei Qian (538647)

الموضوعات: